• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Rutgers, Parexel collaborate to optimize clinical trial services

Rutgers, Parexel collaborate to optimize clinical trial services

July 8, 2013
CenterWatch Staff

Rutgers New Jersey Medical School (NJMS) has been selected by Parexel International, a global biopharmaceutical services provider, as a Key Alliance Site. This will give NJMS ongoing, long-term access to trial opportunities through Parexel’s client base.

NJMS will provide Parexel with the opportunity to place early to late phase studies, exposure to experienced investigators for clinical trial design and access to information resources through the NJMS electronic medical record system. This integrated arrangement will further enable Paraexel and NJMS to plan, develop and execute clinical trial studies with shorter timelines.

“Our collaboration with Parexel will further strengthen the capabilities of New Jersey Medical School’s clinical research center unit, which conducts clinical trials in a wide variety of medical specialties,” says William C. Gause, senior associate dean for research at NJMS, which became part of the newly created Rutgers Biomedical and Health Sciences unit within Rutgers in July.

“This partnership further enhances the global research, educational and service missions of the entire new Rutgers, as it strengthens both our clinical research capabilities and our potential to enhance health care delivery for the people throughout the state,” said Kenneth Breslauer, vice president for health science partnerships at Rutgers. 

Clinical trials hosted at the NJMS clinical research center unit will evaluate medications and other products designed to treat a wide range of conditions, including cancer, obesity and diabetes as well as cardiovascular, respiratory and infectious diseases. Many trials will be conducted through collaboration with University Hospital, the flagship teaching hospital for New Jersey Medical School.

“Ultimately, Parexel and NJMS are aligning and mobilizing knowledge and resources to bring new products to market through more efficient clinical trials,” said Lollo Eriksson, Parexel’s vice president, clinical research services and global site alliances.

Established in 1766, Rutgers, The State University of New Jersey, is America’s eighth oldest institution of higher learning and a public research university. Rutgers Biomedical and Health Sciences (RBHS) is the healthcare education, research and clinical division of Rutgers University, comprising nine schools and their attendant faculty practices, centers, institutes and clinics; New Jersey’s comprehensive cancer care center; and New Jersey's largest behavioral healthcare network.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing